
Give the Gift of Choice!
Too many options? Treat your friends and family to their favourite stores with a Bayshore Shopping Centre gift card, redeemable at participating retailers throughout the centre. Click below to purchase yours today!Purchase HereHome
Advancing Menopause Care: Bridging Evidence, Practice, and Innovation, An Issue of Obstetrics and Gynecology Clinics of North America, 1e
Coles
Loading Inventory...
Advancing Menopause Care: Bridging Evidence, Practice, and Innovation, An Issue of Obstetrics and Gynecology Clinics of North America, 1e in Ottawa, ON
By None
Current price: $149.99


By None
Advancing Menopause Care: Bridging Evidence, Practice, and Innovation, An Issue of Obstetrics and Gynecology Clinics of North America, 1e in Ottawa, ON
Current price: $149.99
Loading Inventory...
Size: Hardcover
*Product information may vary - to confirm product availability, pricing, shipping and return information please contact Coles
In this issue of Obstetrics and Gynecology Clinics of North America , Dr. Jill Liss brings her considerable expertise to the topic of Advancing Menopause Care: Bridging Evidence, Practice, and Innovation . Top experts provide a comprehensive exploration of menopause care, equipping healthcare providers with evidence-based strategies to navigate key challenges, including misinformation, diverse patient needs, and access to therapies, while offering special attention to emerging treatments such as NK3 receptor antagonists, weight management strategies, and the optimization of hormone therapy.
In this issue of Obstetrics and Gynecology Clinics of North America , Dr. Jill Liss brings her considerable expertise to the topic of Advancing Menopause Care: Bridging Evidence, Practice, and Innovation . Top experts provide a comprehensive exploration of menopause care, equipping healthcare providers with evidence-based strategies to navigate key challenges, including misinformation, diverse patient needs, and access to therapies, while offering special attention to emerging treatments such as NK3 receptor antagonists, weight management strategies, and the optimization of hormone therapy.

















